The CEO of virtual-care veteran Omada shares why he's avoiding the race to prescribe trendy new weight-loss drugs and what he's doing instead
by offering coaching and connected devices to help more than 800,000 patients manage their diabetes and other chronic conditions. Now, as the rise of these powerful drugs upends the weight-loss industry, Omada is grappling with how it can play a role.
"Omada's gonna do pretty much the exact opposite of what we're seeing in the digital-health landscape in our competitive set and actually not write GLP scripts," CEO Sean Duffy told Insider in an interview. But here's where Omada is making a big gamble: It wants to help people stop taking the drugs after a period of time. The goal is that by changing their habits, Omada can help patients keep a lot of the weight off, even though clinical-trial dataThe program will launch with a large employer in July, Duffy said.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Opinion: Ozempic for weight loss is all the rage, but so is fighting fatphobiaYou've read the stories about miracle weight loss drugs? The real miracle would be to stop blaming fat people for being fat.
Read more »
Flagler Health+ and UF Health reach an agreement to mergeFlagler Health+ and UF Health have reached a final agreement to integrate Flagler Health+ into UF Health.
Read more »
Heart health to be the topic of an upcoming health fairLocal medical professionals will speak about cardiovascular health and offer blood pressure screenings as a part of a free health fair.
Read more »
Contra Costa County Health lifts health advisory from mercury spillContra Costa County has lifted a health advisory for downtown Martinez, eight days after a mercury spill was discovered near the Amtrak station.
Read more »
Good mental health at every age | Office on Women's Health
Read more »
Ozempic Is Hard to Find. Some Pharmacies Are Offering Unauthorized Alternatives.When Carrie Davis found out that her health insurance wouldn’t cover Ozempic, she sought an alternate route to getting the diabetes drug, which is increasingly being used off-label for weight loss. Davis, 55, did not have diabetes, but she had gained 50 pounds during menopause and developed hypothyroidism, she said, and was eager to lose weight. After seeing someone claiming to be a doctor on TikTok saying he could help patients obtain a generic version of the medication, she reached out. After
Read more »